Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4IAJ4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.537 |
CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.416 |
CLV_PCSK_PC1ET2_1 | 62 | 64 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 90 | 92 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.448 |
DEG_SPOP_SBC_1 | 21 | 25 | PF00917 | 0.463 |
DOC_MAPK_gen_1 | 62 | 68 | PF00069 | 0.405 |
LIG_14-3-3_CanoR_1 | 63 | 67 | PF00244 | 0.402 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.471 |
LIG_BRCT_BRCA1_1 | 31 | 35 | PF00533 | 0.383 |
LIG_BRCT_BRCA1_1 | 51 | 55 | PF00533 | 0.537 |
LIG_BRCT_BRCA1_2 | 51 | 57 | PF00533 | 0.390 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.444 |
LIG_LIR_Gen_1 | 65 | 75 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.416 |
LIG_SH2_CRK | 45 | 49 | PF00017 | 0.448 |
LIG_SH2_CRK | 85 | 89 | PF00017 | 0.481 |
LIG_SH2_NCK_1 | 45 | 49 | PF00017 | 0.359 |
LIG_SH2_SRC | 45 | 48 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.345 |
LIG_SUMO_SIM_anti_2 | 2 | 9 | PF11976 | 0.518 |
LIG_TYR_ITIM | 43 | 48 | PF00017 | 0.444 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.447 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.434 |
MOD_GlcNHglycan | 30 | 34 | PF01048 | 0.367 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.443 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.520 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.414 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.615 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.514 |
MOD_PKA_1 | 62 | 68 | PF00069 | 0.410 |
MOD_PKA_1 | 90 | 96 | PF00069 | 0.599 |
MOD_PKA_2 | 62 | 68 | PF00069 | 0.410 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.599 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.447 |
MOD_SUMO_for_1 | 56 | 59 | PF00179 | 0.602 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.475 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PE77 | Leptomonas seymouri | 82% | 100% |
A0A0S4KJ18 | Bodo saltans | 47% | 100% |
A0A1X0PB28 | Trypanosomatidae | 52% | 98% |
A0A3R7MX32 | Trypanosoma rangeli | 57% | 98% |
A0A3S7X8J4 | Leishmania donovani | 100% | 100% |
A4HBE6 | Leishmania braziliensis | 90% | 100% |
C9ZLP6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 68% |